Dr. Nicole Carreau, MD

Dr. Carreau practices at Nuvance Health Medical Practice CT, Inc. in Danbury, Connecticut.

Dr. Carreau's NPI, 1104168962, was assigned on March 20, 2013. Dr. Carreau graduated from University of Connecticut School of Medicine in 2013. Dr. Carreau holds Connecticut license 64829.

Dr. Carreau's primary practice is Nuvance Health Medical Practice CT, Inc., at 100 Reserve Rd, Danbury, CT 06810 in Western Ct County. The practice phone is (203) 739-7742.

Dr. Carreau's primary practice is Nuvance Health Medical Practice CT, Inc. in Danbury, Connecticut. Dr. Carreau is also affiliated with Northwell Danbury Hospital. The medical group on file is Danbury Medical Group. Dmand AI also links Dr. Carreau to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carreau practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Carreau's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Carreau is board certified in hematology by the American Board of Internal Medicine. Dr. Carreau is licensed in Connecticut.

CMS data shows 1,375 Medicare services from Dr. Carreau across 9 procedure codes in 2024, for 188 Medicare patients. Medicare paid $77,407 for them.

CMS counts 188 Medicare patients who saw Dr. Carreau in 2024. The largest group is 75 to 84, with 74 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 16% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carreau's median patient age at 72, with 56% women.

In 2024, Dr. Carreau wrote 378 Medicare Part D claims for 72 patients. 56% of them were for generic drugs. CMS names the drug for 252 of them, across 9 drugs with 11 or more claims each, at $732,476 in total drug cost. In 2023, CMS named 173 claims across 9 drugs.

Dr. Carreau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carreau as offering telehealth.

Dmand AI links 10 papers to Dr. Carreau, published from 2015 to 2020. 2020 was the busiest year, with 3. The most frequent topics are Melanoma, Programmed Cell Death 1 Receptor and Skin Neoplasms. Dr. Carreau's most frequent co-authors are Philippe Armand, MD, PhD, Steven M. Bair, MD and Kevin Andrew David, MD.

CMS Open Payments shows 110 general payments to Dr. Carreau from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Bristol-Myers Squibb Company paid the most, $1,179.

Dr. Carreau graduated from University of Connecticut School of Medicine in 2013.